For the quarter ended June 2024, Aveanna Healthcare (AVAH Quick QuoteAVAH - Free Report) reported revenue of $504.96 million, up 7% over the same period last year. EPS came in at $0.01, compared to -$0.02 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $494.02 million, representing a surprise of +2.22%. The company delivered an EPS surprise of +150.00%, with the consensus EPS estimate being -$0.02.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Aveanna performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenue- PDS

  : $407.85 million versus $396.11 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +8% change.

• Revenue- MS

  : $42.48 million compared to the $40.88 million average estimate based on three analysts. The reported number represents a change of +9.3% year over year.

• Revenue- HHH

  : $54.63 million versus the three-analyst average estimate of $55.25 million. The reported number represents a year-over-year change of -1.4%.

View all Key Company Metrics for Aveanna here>>>

Shares of Aveanna have returned +33.5% over the past month versus the Zacks S&P 500 composite's -6.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.